Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
AFT Ribeiro, M Pratcorona… - Blood, The Journal …, 2012 - ashpublications.org
The prevalence, the prognostic effect, and interaction with other molecular markers of
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
[引用][C] Mutant DNMT3A: A marker of poor prognosis in acute myeloid leukemia
A Ribeiro, M Pratcorona, C Erpelinck, V Rockova… - Blood, 2012 - repub.eur.nl
RePub, Erasmus University Repository: Mutant DNMT3A: A marker of poor prognosis in
acute myeloid leukemia university website Wealth Erasmus Research Institute of …
acute myeloid leukemia university website Wealth Erasmus Research Institute of …
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
AFT Ribeiro, M Pratcorona… - …, 2012 - pubmed.ncbi.nlm.nih.gov
The prevalence, the prognostic effect, and interaction with other molecular markers of
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
[引用][C] Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
AF TIBURCIO RIBEIRO, M PRATCORONA, PJM VALK… - Blood, 2012 - pascal-francis.inist.fr
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
[PDF][PDF] Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
PJM Valk, R Delwel - BLOOD, 2012 - academia.edu
Acute myeloid leukemia (AML) is a heterogeneous group of malignancies with different
clinical behavior and different responses to therapy. AML can be classified according to …
clinical behavior and different responses to therapy. AML can be classified according to …
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
AFT Ribeiro, M Pratcorona, C Erpelinck-Verschueren… - Blood, 2012 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The prevalence, the prognostic effect, and
interaction with other molecular markers of DNMT3A mutations was studied in 415 patients …
interaction with other molecular markers of DNMT3A mutations was studied in 415 patients …
[HTML][HTML] Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
AFT Ribeiro, M Pratcorona, C Erpelinck-Verschueren… - Blood, 2012 - Elsevier
The prevalence, the prognostic effect, and interaction with other molecular markers of
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
AFT Ribeiro, M Pratcorona… - Blood, 2012 - scholarship.miami.edu
The prevalence, the prognostic effect, and interaction with other molecular markers of
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia.
AF Ribeiro, M Pratcorona, C Erpelinck-Verschueren… - Blood, 2012 - europepmc.org
The prevalence, the prognostic effect, and interaction with other molecular markers of
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
DNMT3A mutations was studied in 415 patients with acute myeloid leukemia (AML) younger …
[引用][C] Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
R AF - Blood, 2012 - cir.nii.ac.jp